Richard Pietras to Survival Analysis
This is a "connection" page, showing publications Richard Pietras has written about Survival Analysis.
Connection Strength
0.167
-
Randomized phase II study of fulvestrant and erlotinib compared with erlotinib alone in patients with advanced or metastatic non-small cell lung cancer. Lung Cancer. 2018 09; 123:91-98.
Score: 0.145
-
Expression levels of estrogen receptor beta in conjunction with aromatase predict survival in non-small cell lung cancer. Lung Cancer. 2011 Nov; 74(2):318-25.
Score: 0.022